Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hy… (NCT03711825) | Clinical Trial Compass
CompletedEarly Phase 1
Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults
Australia8 participantsStarted 2018-09-10
Plain-language summary
To assess how long memantine hydrochloride (HCl) (50 mg) extended release capsules stay in the stomach as determined by imaging assessment (MRI or abdominal ultrasound).
To evaluate the safety of a memantine HCl extended release capsule formulation
Who can participate
Age range
18 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Healthy male and female subjects
. Body mass index of 18.0 to 30.0 kg/meters-squared
. Suitable scores for two swallowing questionnaires
. Demonstrate normal swallowing and gastrointestinal passage for capsule, as assessed while undergoing imaging studies
. Must provide written informed consent
Exclusion criteria
. Participants who have previously been enrolled in this study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Gastric retention by imaging assessment by MRI
Timeframe: Up to 9 days post-dosing
2
Gastric retention by imaging assessment by abdominal U/S
Timeframe: Up to 9 days post-dosing
3
Safety and tolerability of a single dose of LYN-057 extended release capsule
Timeframe: Through study completion, up to 3 months